Abstract

Background: Trachoma is a communicable infection of the eye by certain strains of the Chlamydia trachomatis. It is the principal cause of loss of sight globally. Mass drug administration (MDA) with azithromycin is a foundation stone of World Health Organization (WHO)’s global struggle to eradicate trachoma by 2020. 
 Aims: The main objectives of the campaign's third monitoring are to check improvement of interventions and improvement of quality across times and activities implemented in seven selected districts of Ibb and Al-Hodeida governorates, Yemen.
 Methods: A community based cross-sectional coverage survey was performed. 68 divisions were selected per selected districts of the two governorates. A disconnect Results Entry Form for each district surveyed was finished, saved and uploaded directly into the online Coverage Survey Analysis Tool to check improvement of interventions and improvement of quality across times and activities implemented.
 Results: The national campaign for MDA covers 966 villages in 6 districts of Ibb and Al-Hodeidah governorates by 1932 healthcare workers. A total number of beneficiaries who were monitored from 476 homes reached 3,077, of whom 2,755 (90%, coverage rate) took the dose. The availability rates of trachoma medicines were ranged from 82% to 91% . The improper arrangement of treatment sessions rate was 17%, the incorrect position of the dose pole was 6%, while the correct records of drugs scored the rate of 99%, and the proper storage of drugs rate was 70%. The community collaboration during the treatment campaign the acceptable rate was 92%, while 3% exhibited unacceptable behaviors towards the treatment campaign.
 Conclusion: In this survey, the national campaign for MDA in the 966 villages reach the target threshold (i.e. 90%) for effective coverage; with proper rates for the availability of trachoma medicines, good people reactions towards taking treatment, and the community collaboration; while bad rates for the improper arrangement of treatment sessions , the incorrect position of the dose pole and the preparation dosages by MDA team. Hence, programmatic enhancement should be made for the future campaign to achieve the estimated thresholds.
 
 Peer Review History: 
 Received 8 March 2021; Revised 29 March; Accepted 25 April, Available online 15 May 2021
 UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency. 
 Received file: Reviewer's Comments:
 Average Peer review marks at initial stage: 6.5/10
 Average Peer review marks at publication stage: 8.0/10
 Reviewer(s) detail:
 Dr. Bilge Ahsen KARA, 
 Ankara Gazi Mustafa Kemal Hospital, Turkey, ahsndkyc@gmail.com
 Dr. Muhammad Zahid Iqbal,
 AIMST University, Malaysia, drmmziqbal@gmail.com
 Dr. A.A. Mgbahurike,
 University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com
 Similar Articles:
 BACTERIAL CAUSES AND ANTIMICROBIAL SENSITIVITY PATTERN OF EXTERNAL OCULAR INFECTIONS IN SELECTED OPHTHALMOLOGY CLINICS IN SANA’A CITY 
 BACTERIAL CONJUNCTIVITIS OF ADULTS: CAUSES AND OPHTHALMIC ANTIBIOTIC RESISTANCE PATTERNS FOR THE COMMON BACTERIAL ISOLATES

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.